D-0176-2023 Class II Terminated
FDA drug recall D-0176-2023 was initiated by Nephron Sc Inc on Jan 13, 2023 and is designated Class II. Reason for recall: Short Fill The recall status is terminated (terminated Oct 11, 2024). Affected quantity: 925,920 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Feb 1, 2023
- Initiation Date
- Jan 13, 2023
- Termination Date
- Oct 11, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 925,920 vials
Product Description
S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9
Reason for Recall
Short Fill
Distribution Pattern
Nationwide within the United States including Puerto Rico. Guatamala
Code Information
Lot #: 126461, 126431 Exp. 04/30/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0176-2023
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026